chrisvoncsefalvay/vaers-outcomes huggingface dataset:
58 y/o female with history of severe seafood allergy presented to ED on 12/24 at 933am with hoarseness, sensation of throat closing. Stated received Covid vaccine at 0730 this morning. Patient took claritin and prednisone prior to vaccine and 20 minutes prior to arrival to ED took benadryl. Symptoms have improved since arrival to ED. Presenting with symptoms of difficulty swallowing. No difficulty breathing, no itching, no rash, no swelling and no wheezing. One dose of Prednisone 40mg tablet given orally at 0955am. Patient monitored and then discharged to home at 1027am with prescription for Prednisone 20 mg by mouth daily for 4 days and to follow-up with primary physician.
This spontaneous report has been received from an registered nurse referring to a unspecified number of patients of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL (strength, route of administration, dose, frequency, lot# and expiration date were unspecified by the reporter) for prophylaxis. The reporter stated that the administered vaccines experienced two temperature excursions: the first one between 32F and 36F for 57 hours, and the other one between 46F and 77F for 24 hours. No previous temperature excursions were reported and the reported information was not registered in a digital data logger. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA000341: US-009507513-1703USA000340.
Patient was given the Pfizer bivalent 12+ instead of the Pfizer bivalent 5-11.
Big time vertigo; Killer headache; Queasy stomach; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 25Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 76 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VERTIGO (non-serious) with onset 27Oct2023, outcome "recovering", described as "Big time vertigo"; HEADACHE (non-serious) with onset 27Oct2023, outcome "recovering", described as "Killer headache"; NAUSEA (non-serious) with onset 27Oct2023, outcome "recovered" (30Oct2023), described as "Queasy stomach". Therapeutic measures were not taken as a result of vertigo, headache, nausea.  Additional information: Patient was calling about the latest Pfizer covid vaccine he had and states he was calling to report adverse reactions and he had the vaccine last Wednesday on 25Oct2023 and then on Friday 27Oct2023 he woke up that morning with a killer headache and big-time vertigo and a queasy stomach and he was ok now but it came out of the blue and it could be a coincidence. For the headache, states initially no it was not ongoing, and it was just a little spacey but it was definitely getting better; On Friday and Saturday he had to turn the TV way down and told his wife not to be loud and clarified the headache was just about gone and was getting better. Vertigo: It was just slightly where what he was doing was not stumbling around like he was on Friday and the vertigo was definitely improved. Queasy stomach: It was not ongoing and states it resolved today and he was still queasy yesterday. No other medical conditions to include and states he was pretty healthy. No treatment required for the reported events, and he just thought it would go away and it did. There were no other products administered to patient.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
feel sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feel sick) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (feel sick). At the time of the report, ILLNESS (feel sick) outcome was unknown. Not Provided          For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. No concomitant and treatment medications were reported.   This case was linked to MOD-2021-091976 (Linked Report).; Sender's Comments:  MOD-2021-091976:Wife case
The patient had heat and slight swelling around Arexvy injection site starting 5 to 6 hours after injection. The next morning there was significant swelling around the injection site and throughout the day spreading along the arm. The following day the swelling spread down that side of her body to her foot, eventually having both feet swollen. As of today, a week later, the swelling only remains in the feet and pain has stopped. Patient did not seek medical attention, and did not let us know until today. I recommended she seek care from her primary care physician.
I woke up Sunday at 4am to discover that my bottom left lip was swollen i had blotches on my back things and i was itching i took nothing. Now today which is Tuesday out of nowhere my top right lip is swollen am itching and the palm of my right hand is swollen and my face is swollen. I am now 10 plus weeks pregnant. My due date is March 9th 2022.  I took the pfizer 1 dose
was fine until Thursday evening 4/22/2021.  Started feeling body aches and restless. Friday morniing 4/23/2021. She woke up and went to the bathroom. Go out and fell and went into cardiac arrest.   #12: GAD, Fibromyalgia, migraine, ventral hernia, hypothyroid, hypercholesterolemia, neuropathy, Hx of Covid-19
Patient received shingles vaccine at local pharmacy. Shot placed in wrong location on arm. Three days later pt seen in office by PCP w/6 cm x 5.5 cm lesion raised about 2 cm. Warm, red, tender (left deltoid).
Within 5 minutes after receiving vaccine and still in waiting area, developed a strong metallic taste in my mouth; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 10Sep2021 11:45 (Lot number: FE3592) at the age of 64 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; GLIPIZIDE; PANTOPRAZOLE; JANUVIA; EZETI. Past drug history included: Ampicillin, reaction(s): "known allergies: Ampicillin", notes: Ampicillin. The following information was reported: DYSGEUSIA (non-serious) with onset 10Sep2021 11:45, outcome "recovering", described as "Within 5 minutes after receiving vaccine and still in waiting area, developed a strong metallic taste in my mouth". Therapeutic measures were not taken as a result of dysgeusia.  Additional information: No covid prior vaccination. Not tested for tested post vaccination.   No follow-up attempts are possible. No further information is expected.
29 year old male with a PMHx of sickle cell disease, chr hyperbilirubinemia, tobacco dependence, THC use , reactive airway disease, chronic hepatitis C, , Hx pylori positive( Tx with triple antibiotic regimen ) . He has a Hx of multiple hospitalization. He was recently admitted to hospital 1/21-1/25/2023 for Sickle cell pain crisis, Tx with IVF , analgesic and narcotics.  Pt's hemoglobin remained in 8's, retic count improved/down trended from 16.8 to 10.49% on the day of discharge. Presented to ED with generalized body aches , similar to his previous pain crisis. Also reported  fever, chills, myalgia , sore throat and dry cough from last 3 days.  His friend also had cold symptoms from last few days. Admitted with diagnosis of sickle cell crisis and COVID -19 infection. Not hypoxic , placed on Remdesivir for 5 days course and now afebrile from last almost >48 hours . Also received IVF, analgesic and narcotic for pain management. Patient was given IVF hydration from last 5 days, Hb dropped to 6.9 due to hemodilution , no indication for transfusion, before discharge rechecked and it was 7.3. Outpatient CBC ordered.  Patient will be discharged home today.
I ended up have abdominal pain. The reaction wasn't from the flu shot. I had gallstones, and had to have my gallbladder removed. My symptoms weren't from the flu shot.
Rashes, severe body itch. Almost hive like, come and  go, only started after second vaccine, still have it to this day, I have these itchy rash spots from my legs, scrotom, thighs, arms stomach
Myalgia, Fever, chills Narrative: fever, chills, body aches
3 days post vaccine injected arm became red/swollen/warm down to elbow - a couple days later she broke out in  a rash all over her body. Everything resolved after about a week - she medicated with benadryl.  Patient came in for 2nd dose and pre-medicated with Benadryl per doctor's orders (they still wanted her to receive the 2nd dose)
Vaccine administered to patient expired on 10-4-2020.  (Today is 10-21-2020)
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 01-MAY-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R002086, expiry date 22-APR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
Almost 3 weeks after the injection I experienced arm pain, fever, nausea,  and chills. It lasted about 12 hours. I had had a reaction on the day of the shot also and that included fever, joint and muscle pain.
1. severe pain left arm, hand numb and tingling.  chest little tight, tongue felt funny, felt like something in back of throat.  Had a rush of heat from chest to head like a flush feeling. Happened  10 minutes after leaving facility after my 15 wait period. Left went to vehicle sitting in vehicle going over grocery list and that is when the pain started in arm and rest followed went back in facility they made me sit in the back for while.  Had real bad cotton mouth. Left after about half hour on way home had severe  pain in lower back kidney area on the left. The pain subsided in kidney area to a dull ache that lasted all day on the 10th and little on the 11th.  Had the cotton mouth for 3 days.
BEGINNING THE EVENING OF THE DAY THE BABY WAS VACCINATED, HE HAD LONG PERIODS (SEVERAL HOURS) OF INCONSOLABLE SCREAMING.  THIS CONTINUED UNTIL THE MORNING OF 03/06/2014, AT WHICH POINT HE EXPERIENCED ABOUT 30 MINUTES OF INTERMITTENT SEIZURE ACTIVITY, FOLLOWED BY A PERIOD OF UNRESPONSIVENESS, CYANOSIS, HYPERGLYCEMIA, AND HYPOTHERMIA.
Injection site swelling; Injection site redness; Large knot at injection site; Injection site discolouration; Tender to touch; 2nd degree burn; Received 2nd dose subcutaneously left arm; Huge knot at injection site; pain at the injection site 2nd dose felt like stab wounds; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Received 2nd dose subcutaneously left arm), VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE INDURATION (Large knot at injection site) and VACCINATION SITE DISCOLOURATION (Injection site discolouration) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Codeine).   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Received 2nd dose subcutaneously left arm). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE INDURATION (Large knot at injection site), VACCINATION SITE DISCOLOURATION (Injection site discolouration) and TENDERNESS (Tender to touch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 28-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Received 2nd dose subcutaneously left arm) had resolved. At the time of the report, VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE INDURATION (Large knot at injection site) outcome was unknown and VACCINATION SITE DISCOLOURATION (Injection site discolouration) and TENDERNESS (Tender to touch) had not resolved.            No concomitant medications were reported.    This case was linked to MOD-2021-067614 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: VAERS: Out come of the event and New events added. Allergy to Codeine added.
nose a little stuffy; throat a little sore; feeling tired; fever; chills; headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nose a little stuffy), OROPHARYNGEAL PAIN (throat a little sore), FATIGUE (feeling tired), PYREXIA (fever) and CHILLS (chills) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced NASAL CONGESTION (nose a little stuffy), OROPHARYNGEAL PAIN (throat a little sore), FATIGUE (feeling tired), PYREXIA (fever), CHILLS (chills), HEADACHE (headache) and MYALGIA (body aches). On 06-Apr-2021, NASAL CONGESTION (nose a little stuffy) and OROPHARYNGEAL PAIN (throat a little sore) had resolved. At the time of the report, FATIGUE (feeling tired), PYREXIA (fever), CHILLS (chills), HEADACHE (headache) and MYALGIA (body aches) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-068508 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068508:CROSS LINKED WITH DOSE 1
This spontaneous report received from a patient, concerned a patient of unspecified age and gender. The patient's height, weight, medical history, concomitant medications and concurrent conditions not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch/lot number: not reported) dose, start therapy date: not reported, for immunization. The batch number was not reported. Unable to perform follow-up to request batch/lot numbers. On an unspecified date, patient experienced complication. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome of complication: not reported.
Pharmacist working at verification station was informed by an out-window staff that a patient was not feeling well after a vaccination. The patient was administered the 1st dose of Covid 19 vaccine (Moderna) by our tech immunizer. Before administering the vaccine the RPH went over common side effects and reactions. Upon calling RPH ran out with emergent kit with EpiPen, Benadryl and first aid kits. By the time the RPH approached the patient, he was sitting on a chair next to his parent. The pharmacist offered to call 911, however the patient's dad declined the offer.  The pharmacist asked few questions to patient to see his health status. Patient was well oriented and no signs of any adverse reactions, and patient stated that he was doing fine. Patient's dad commented that his son is scared of needles all the time and it happens frequently when he's getting immunizations. Pharmacist recommended to patient and his dad in the future it would be advisable to get vaccines at medical facility under doctor's supervision. Pharmacist stayed with the patient for a while for observation until the patient left pharmacy to grab some snacks. No further adverse reactions observed. However earlier today, after few weeks of the incident, patient's dad showed up to the pharmacy counter stating that his son had breathing problems on after Covid vaccination and he was administered an inhaler. In addition, the patient's dad wanted us to report the incident because his doctor's office is requesting an incident report. We filed the incident report internally and communicated to patient's dad we reported VAERS.
Pt. recv'd the flu shot on 10/4/11. After leaving had a very sore and painful arm.
I inadvertantly administered an extra dose of Tdap vaccine three days apart. Patient denies any adverse side effects.
lupus; rheumatoid arthritis; cervical cancer requiring hysterectomy by the age of 24; severe (also reported as several) autoimmune diseases; raynauds; POTS; inappropriate sinus tachycardia; high blood pressure; intractable migraines; food intolerances to red meat and dairy; food intolerances to red meat and dairy; IBS; health continues to deteriorate; This spontaneous report was received via social media monitoring from a lawyer, regarding an on-line article authored by the lawyer that involved a lawsuit (case in litigation), and refers to a 17-year-old female patient (pt) whose age at vaccination with the suspect vaccine was not provided. The pt's pertinent medical history, concomitant medications or drug reactions/allergies were not not provided.  On an unknown date, the pt consented and was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (also referred to as "Gardasil human papillomavirus (HPV) vaccine") (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis.  On an unknown date, the patient reacted to the suspect vaccine developing severe (also reported as several) autoimmune diseases, lupus, rheumatoid arthritis, Raynauds, postural orthostatic tachycardia syndrome (POTS), inappropriate sinus tachycardia, high blood pressure, intractable migraines, food intolerances to red meat and dairy, irritable bowel syndrome (IBS), cervical cancer requiring hysterectomy by the age of 24, and the pt's health continued to deteriorate. The pt inquired a physician about how to have her blood tested for the presence of the HPV-16 L1 fragment and any costs associated with that testing. The pt stated she had been unable to find treatment or recovery as her health continued to deteriorate.  The outcome of the events was not recovered/not resolved (provided as present status: not recovered). The reporter considered the events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (provided as reacted to the suspect vaccine developing the reported events).  Upon internal review, the events of autoimmune disorder, cervix carcinoma, rheumatoid arthritis, and systemic lupus erythematosus were determined to be medically significant.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2101USA011807:
Patient presented with pleuritic chest pain for 2 days after her second Pfizer vaccine dose. Symptoms were accompanied by shortness of breath, tachycardia, and elevated troponin. EKG showed normal sinus tachycardia without ST segment/T waves/PR  changes. CT PE was negative. Further NSTEMI rule-out was negative. Denied fever, nausea, vomiting, headaches, palpitations.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 03-NOV-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Vls 10 SDV) (Lot # K007822, expiration date 15-AUG-2016) single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, the PNEUMOVAX had a temperature excursion for 804 hours, the lowest recorded temperature was 20F (-6.667 Celsius). The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
Blood pressure on day of first vaccination was 135/80, consistent with previous two years of blood pressure readings.  Next blood pressure reading was on 07/15/2021 at 160/185.  After EKG, chest x-ray, and CT scan, an enlarged aorta was discovered.  No other changes in health, diet, lifestyle, or activity during that period.
Began having neurological symptoms and painful muscular contractions in body extremities within several days. Lasted for months, still is not fully resolved.
Fever; Sweats; Chills; Extreme tiredness; Migraine; Weakness; Cough; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included crohn's, asthma, spasmodic dysphonia, depression, anxiety and post-traumatic stress disorder (PTSD). The patient had received medication which was not specified within two weeks of vaccination for unknown indication and unknown if ongoing. The patient previously took pethidine hydrochloride (DEMEROL), ciclosporin (CYCLOSPORINE), infliximab (REMICADE) and sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 19:00, the patient experienced fever, sweats, chills, extreme tiredness, migraine, weakness, cough, nausea. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events fever, sweats, chills, extreme tiredness, migraine, weakness, cough, nausea was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.